2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Multiple Myeloma
237
Precursor Cell Lymphoblastic Leukemia-Lymphoma
69
Recurrence
36
Burkitt Lymphoma
34
Leukemia
32
Lymphoma
30
Neoplasms, Plasma Cell
22
Lymphoma, Non-Hodgkin
19
Immunoglobulin Light-chain Amyloidosis
18
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
17
Lymphoma, Mantle-Cell
16
Neoplasms
15
Nausea
15
Lymphoma, Large B-Cell, Diffuse
15
Vomiting
14
Hodgkin Disease
13
Breast Neoplasms
12
Waldenstrom Macroglobulinemia
11
Leukemia, Biphenotypic, Acute
11
Lymphoma, Follicular
10
Lymphoma, B-Cell, Marginal Zone
10
Amyloidosis
10
Lung Neoplasms
9
Smoldering Multiple Myeloma
8
Prostatic Neoplasms
8
Neoplasm Metastasis
8
Leukemia, Myeloid, Acute
8
Hematologic Neoplasms
7
Blast Crisis
7
Lymphoma, T-Cell, Cutaneous
6
Interventions
Gemcitabine
13
pembrolizumab
9
Specimen Handling
9
enfortumab vedotin
8
Cisplatin
8
Magnetic Resonance Spectroscopy
7
avelumab
5
Carboplatin
5
vinflunine
4
Nivolumab
4
atezolizumab
3
Immunoglobulin G
3
Disulfides
3
Biopsy
3
eribulin
2
cabozantinib
2
Standard of Care
2
Ramucirumab
2
Radiotherapy
2
Platinum
2
Nephroureterectomy
2
Ipilimumab
2
Doxorubicin
2
Docetaxel
2
CTLA-4 Antigen
2
Bortezomib
2
1,2-diaminocyclohexaneplatinum II citrate
2
vandetanib
1
tremelimumab
1
tocilizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ureteral Neoplasms
×
Calcium Dobesilate
×
Clear all
NCT03193788
2017-06-21
PREMIER
Asan Medical Center
Phase 3
Unknown
74 enrolled